The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

BABIES born very prematurely in Northern Ireland will be offered a single long-acting injection against respiratory syncytial ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

New UK data shows RSV vaccines in pregnant women cut infant hospitalizations by 72%, while premature babies are now protected ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

The new injection, Nirsevimab, will be given to high-risk babies, including those born too early to be protected by the RSV ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

AS01-adjuvanted RSV and shingles vaccines were tied to a lower dementia risk in older adults. Compared with flu vaccine recipients, those who had the AS01 RSV shot had 29% more dementia-free time ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.